Mechanistic and functional differentiation of tapentadol and tramadol
- 15 June 2012
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Pharmacotherapy
- Vol. 13 (10), 1437-1449
- https://doi.org/10.1517/14656566.2012.696097
Abstract
Introduction: Many opioid analgesics share common structural elements; however, minor differences in structure can result in major differences in pharmacological activity, pharmacokinetic profile, and clinical efficacy and tolerability. Areas covered: This review compares and contrasts the chemistry, pharmacodynamics, pharmacokinetics, and CNS ‘functional activity' of tapentadol and tramadol, responsible for their individual clinical utilities. Expert opinion: The distinct properties of tapentadol and tramadol generate different CNS functional activities, making each drug the prototype of different classes of opioid/nonopioid analgesics. Tramadol's analgesia derives from relatively weak µ-opioid receptor (MOR) agonism, plus norepinephrine and serotonin reuptake inhibition, provided collectively by the enantiomers of the parent drug and a metabolite that is a stronger MOR agonist, but has lower CNS penetration. Tapentadol's MOR agonist activity is several-fold greater than tramadol's, with prominent norepinephrine reuptake inhibition and minimal serotonin effect. Accordingly, tramadol is well-suited for pain conditions for which a strong opioid component is not needed—and it has the benefit of a low abuse potential; whereas tapentadol, a schedule-II controlled substance, is well-suited for pain conditions requiring a strong opioid component—and it has the benefit of greater gastrointestinal tolerability compared to classical strong opioids. Both drugs offer distinct and complementary clinical options.This publication has 52 references indexed in Scilit:
- Lessons Learned from Molecular Scaffold AnalysisJournal of Chemical Information and Modeling, 2011
- Thermodynamics of Ligand Binding and EfficiencyACS Medicinal Chemistry Letters, 2011
- Thermodynamics guided lead discovery and optimizationDrug Discovery Today, 2010
- Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved DrugsJournal of Chemical Information and Modeling, 2010
- Molecular Shape and Medicinal Chemistry: A PerspectiveJournal of Medicinal Chemistry, 2010
- Differential tramadol and O-desmethyl metabolite levels in brain vs. plasma of mice and rats administered tramadol hydrochloride orallyJournal of Clinical Pharmacy & Therapeutics, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 2001
- Three-Dimensional Shape-Based Searching of Conformationally Flexible CompoundsJournal of Chemical Information and Computer Sciences, 1997
- The Properties of Known Drugs. 1. Molecular FrameworksJournal of Medicinal Chemistry, 1996
- Opioid AnalgesicsPublished by Springer Science and Business Media LLC ,1986